TSHATaysha Gene Therapies, Inc.
What is the market doing?
The market is leaning against it: in a downtrend (−26% vs 200-day) and a crowded short (+17% of shares).
In a downtrend, below its 50- and 200-day averages. Price is −26% vs its 200-day average.
A crowded short, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How TSHA is trading
Taysha Gene Therapies, Inc. is −22% over the past year while the S&P 500 is +16%: 38 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −26%
vs 200-day average · a clear downtrend
- RSI (14)
- 38
RSI (14) · neutral
- Below its 52-week high
- 43%
Below its 52-week high
Details›
- Last close2026-10-23
- $3.97
- 1 monthS&P 500 −0.94%
- −17%
- 1 yearS&P 500 +16%
- −22%
- 5 yearsS&P 500 +86%
- −78%
- vs 50-day average$5.03
- −21%
- 52-week high
- $6.98
- 52-week low
- $3.50
- Annualised volatility
- 96%
| Year | Return |
|---|---|
| 2026 (year to date) | −28% |
| 2025 | +218% |
| 2024 | −2.3% |
| 2023 | −22% |
| 2022 | −81% |
| 2021 | −56% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 0 of 6 | −18% |
| Feb | 6 | 3 of 6 | +9.2% |
| Mar | 6 | 1 of 6 | −10% |
| Apr | 6 | 3 of 6 | +7.9% |
| May | 6 | 2 of 6 | +3.3% |
| Jun | 6 | 2 of 6 | +0.20% |
| Jul | 6 | 3 of 6 | −1.7% |
| Aug | 6 | 5 of 6 | +63% |
| Sep | 6 | 1 of 6 | −9.8% |
| Oct | 7 | 1 of 7 | −6.1% |
| Nov | 6 | 3 of 6 | +14% |
| Dec | 6 | 4 of 6 | −3.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.